PARATEK PHARMACEUTICALS INC's ticker is and the CUSIP is 699374AB0. A total of 19 filers reported holding PARATEK PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $24,375,000 | +25.5% | 25,000,000 | 0.0% | 0.77% | +29.0% |
| Q1 2023 | $19,425,140 | -99.9% | 25,000,000 | 0.0% | 0.60% | +43.3% |
| Q3 2022 | $21,927,000,000 | +3.1% | 25,000,000 | 0.0% | 0.42% | +33.8% |
| Q2 2022 | $21,259,000,000 | -6.7% | 25,000,000 | 0.0% | 0.31% | +42.0% |
| Q4 2021 | $22,780,000,000 | +2.8% | 25,000,000 | 0.0% | 0.22% | +25.9% |
| Q3 2021 | $22,168,000,000 | -3.2% | 25,000,000 | 0.0% | 0.17% | -14.7% |
| Q2 2021 | $22,895,000,000 | -2.4% | 25,000,000 | -3.8% | 0.20% | -39.6% |
| Q1 2021 | $23,448,000,000 | +4.7% | 26,000,000 | 0.0% | 0.34% | -26.0% |
| Q4 2020 | $22,385,000,000 | -1.1% | 26,000,000 | -6.3% | 0.46% | -20.5% |
| Q3 2020 | $22,642,000,000 | +1.4% | 27,750,000 | 0.0% | 0.58% | +16.6% |
| Q2 2020 | $22,339,000,000 | +9.5% | 27,750,000 | 0.0% | 0.49% | +17.4% |
| Q1 2020 | $20,406,000,000 | +2.2% | 27,750,000 | 0.0% | 0.42% | -25.7% |
| Q4 2019 | $19,958,000,000 | -0.3% | 27,750,000 | 0.0% | 0.56% | +1.4% |
| Q3 2019 | $20,019,000,000 | +2.5% | 27,750,000 | 0.0% | 0.56% | +47.4% |
| Q2 2019 | $19,526,000,000 | – | 27,750,000 | – | 0.38% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cohanzick Management, LLC | 25,112,000 | $25,557,982 | 22.10% |
| Westchester Capital Management, LLC | 8,267,000 | $8,308,536 | 0.24% |
| MACQUARIE GROUP LTD | 5,359,000 | $5,386,000 | 0.01% |